RAMM Pharma

RAMM Pharma Net Tangible Assets

The Net Tangible Assets of RAMM Pharma (RAMM.CN) as of Nov 3, 2026 is 5.70 M CAD. In the previous year, Net Tangible Assets was 13.45 M CAD — a change of -57.63% (lower).

Net Tangible Assets

5.70 MCAD

YoY

-57.63%

Last updated:

Net Tangible Assets of RAMM Pharma is 2025 5.70 M CAD. Net Tangible Assets of RAMM Pharma was 2024 13.45 M CAD. It decreases by -57.63% lower compared to the previous year.

The RAMM Pharma Net Tangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Tangible Assets
Date
Net Tangible Assets
Jan 1, 2018
-226,902.00 CAD
Jan 1, 2019
38.13 M CAD
Jan 1, 2020
34.37 M CAD
Jan 1, 2021
41.06 M CAD
Jan 1, 2022
34.78 M CAD
Jan 1, 2023
28.97 M CAD
Jan 1, 2024
13.45 M CAD
Jan 1, 2025
5.70 M CAD
The RAMM Pharma Net Tangible Assets history
YEARNet Tangible AssetsYoY
5.70 MCAD-57.63%
13.45 MCAD-53.59%
28.97 MCAD-16.70%
34.78 MCAD-15.28%
41.06 MCAD+19.44%
34.37 MCAD-9.85%
38.13 MCAD-16,905.09%
-226,902.00CAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

RAMM Pharma Stock analysis

What does RAMM Pharma do? RAMM Pharma Corp generates revenue through cannabinoid pharmaceuticals and cannabis-based products, with brands like NettaLife, NettaPet, NettaPet Senior, NettaPet Puppies, and NettaVet targeting pet owners and veterinary markets. The company also sells cosmetics under the Cannabipiel line, including Cannabipiel Nite, Cannabipiel Body Lotion, and Cannabipiel Shampoo, catering to consumers seeking cannabinoid-infused skincare and personal care solutions. Subsidiaries such as Canapar Corp. and Medic Plast SA support production and commercialization across pharmaceutical specialties, household products, and food sectors. The firm’s product portfolio spans pharmaceuticals, pet care, cosmetics, and household items, with NettaPet and NettaVet focusing on animal health and Cannabipiel products targeting human skincare. Revenue streams include direct sales of branded items like Cannabipiel Tite and Cannabipiel Cleaning Emulsion to retail and specialty markets, while subsidiaries handle manufacturing and export operations for global distribution. Brands like Glediser SA and Yurelan SA contribute to the commercialization of diverse product categories under the company’s umbrella. RAMM Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RAMM Pharma stock

Net Tangible Assets of RAMM Pharma is 5.70 M CAD in 2025.

Net Tangible Assets of RAMM Pharma changed from 13.45 M CAD to 5.70 M CAD, representing a -57.63% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Tangible Assets RAMM Pharma since 2006 – with annual values, charts, and detailed analysis.

Net tangible assets equal total assets minus intangible assets, goodwill, and liabilities. They represent the physical asset backing of a company.

Net Tangible Assets's CAD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Tangible Assets's RAMM Pharma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — RAMM Pharma

All Key Metrics — RAMM Pharma